REFERENCES
1. Bender Atik R., Christiansen O.B., Elson J., Kolte A.M., Lewis S., Middeldorp S., et al. ESHRE guideline: recurrent pregnancy loss // Hum. Reprod. Open. 2018.
2. Brignardello-Petersen R., Bonner A., Alexander P.E., Siemieniuk R.A., Furukawa T.A., Rochwerg B., GRADE Working Group. Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis // J. Clin. Epidemiol. 2018. Vol. 93. Р. 36-44.
3. Rovner P., Stickrath E., Alston M., Lund K. An early pregnancy unit in the United States: an effective method for evaluating firsttrimester pregnancy complications // J. Ultrasound Med. 2018. Vol. 37. Р. 1533-1538.
4. Ordiyants I.M., Barabasheva S.S. Non-developing pregnancy: view of the problem: Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2018; 3: 92-6. (in Russian)
5. Rumyantseva Z.S., Lyumanova E.Yu., Volotskaya N.I., Anikin S.S. Predictors of non-developing pregnancy and role of periconceptional care in prevention of recurrent pregnancy loss. Medical newsletter of Vyatka. 2021. № 1 (69). (in Russian)
6. Devall A., et al. Progestogens for preventing miscarriage: a network metaanalysis // Cochrane Database of Systematic Reviews. 2021. N 4.
7. Volkov V.G., Chursina O.V. A role of comprehensive cervix assessment in the first trimester of pregnancy for predicting preterm. Akusherstvo, ginekologiya, reproduktsiya [Obstetrics, Gynecology, Reproduction]. 2020; 14 (2): 174-181. (in Russian)
8. Zagorodnikova K.A., Rustanovich Yu.G., Kostyuchek D.F., Murzina A.A. The frequency of rs776746 polymorphism in the CYP3A5 gene in women with nondeveloping pregnancy. Farmakogenetika i farmakogenomika [Pharmacogenetics and Pharmacogenomics]. 2018; 1: 27-30. DOI: 10.24411/2588-0527-2018-10005 (in Russian)
9. Brownlea S., Holdgate A., Thou S.T., Davis G.K. Impact of an early pregnancy problem service on patient care and emergency department presentations. Aust N Z J Obstet Gynaecol. 2017; 45: 108-111.
10. Ectopic pregnancy and miscarriage: diagnosis and initial management NICE guideline. 2019.
11. Coomarasamy A., et al. A randomized trial of progesterone in women with bleeding in early pregnancy. N Eng J Med. 2019; 380 (19): 1815-24.
12. Yan Y. et al. Efficacy of progesterone on threatened miscarriage: an updated meta-analysis of randomized trials. Arch Gynecol Obstet. 2021. Vol. 303, N 1. Р. 27-36.
13. Chan D.M., Cheung K.W., Yung S.S., Lee V.C.Y., Li R., Ng E.H. A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial. Trials. 2016; 17 (1): 408.
14. Coomarasamy A., Devall A.J., Brosens J.J., et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020; 223: 167-76.